Literature DB >> 30465754

Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease.

W Robert Bell1, Yang An2, Yusuke Kageyama1, Collin English1, Gay L Rudow1, Olga Pletnikova1, Madhav Thambisetty2, Richard O'Brien3, Abhay R Moghekar4, Marilyn S Albert4, Peter V Rabins5, Susan M Resnick2, Juan C Troncoso6.   

Abstract

INTRODUCTION: Primary age-related tauopathy (PART) is a recently described entity that can cause cognitive impairment in the absence of Alzheimer's disease (AD). Here, we compared neuropathological features, tau haplotypes, apolipoprotein E (APOE) genotypes, and cognitive profiles in age-matched subjects with PART and AD pathology.
METHODS: Brain autopsies (n = 183) were conducted on participants 85 years and older from the Baltimore Longitudinal Study of Aging and Johns Hopkins Alzheimer's Disease Research Center. Participants, normal at enrollment, were followed with periodic cognitive evaluations until death.
RESULTS: Compared with AD, PART subjects showed significantly slower rates of decline on measures of memory, language, and visuospatial performance. They also showed lower APOE ε4 allele frequency (4.1% vs. 17.6%, P = .0046). DISCUSSION: Our observations suggest that PART is separate from AD and its distinction will be important for the clinical management of patients with cognitive impairment and for public health care planning.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Alzheimer disease (AD); Dementia; Mild Cognitive Impairment (MCI); Neurofibrillary tangles; Primary Age-Related Tauopathy (PART); Public Health Planning

Mesh:

Substances:

Year:  2018        PMID: 30465754      PMCID: PMC6542566          DOI: 10.1016/j.jalz.2018.07.215

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  46 in total

1.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.

Authors:  P Giannakopoulos; F R Herrmann; T Bussière; C Bouras; E Kövari; D P Perl; J H Morrison; G Gold; P R Hof
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

2.  Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly.

Authors:  Ira Driscoll; Susan M Resnick; Juan C Troncoso; Yang An; Richard O'Brien; Alan B Zonderman
Journal:  Ann Neurol       Date:  2006-12       Impact factor: 10.422

Review 3.  Lipoproteins in the central nervous system.

Authors:  M J Ladu; C Reardon; L Van Eldik; A M Fagan; G Bu; D Holtzman; G S Getz
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

4.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

Review 5.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

6.  Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.

Authors:  Peter T Nelson; Erin L Abner; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Karen Santacruz; Charles D Smith; Ela Patel; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-07       Impact factor: 3.685

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Phases of A beta-deposition in the human brain and its relevance for the development of AD.

Authors:  Dietmar R Thal; Udo Rüb; Mario Orantes; Heiko Braak
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

Review 9.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  26 in total

Review 1.  Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain.

Authors:  Richard A Hickman; Xena E Flowers; Thomas Wisniewski
Journal:  Curr Neurol Neurosci Rep       Date:  2020-07-14       Impact factor: 5.081

2.  Primary age-related tauopathy in a Chinese cohort.

Authors:  Xin Wang; Lei Zhang; Hui Lu; Juan-Li Wu; Hua-Zheng Liang; Chong Liu; Qing-Qing Tao; Zhi-Ying Wu; Ke-Qing Zhu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

3.  TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related Tauopathy.

Authors:  Denis S Smirnov; David P Salmon; Douglas Galasko; Steven D Edland; Donald P Pizzo; Vanessa Goodwill; Annie Hiniker
Journal:  Ann Neurol       Date:  2022-07-11       Impact factor: 11.274

4.  Genome-wide association study and functional validation implicates JADE1 in tauopathy.

Authors:  Kurt Farrell; SoongHo Kim; Natalia Han; Megan A Iida; Elias M Gonzalez; Marcos Otero-Garcia; Jamie M Walker; Timothy E Richardson; Alan E Renton; Shea J Andrews; Brian Fulton-Howard; Jack Humphrey; Ricardo A Vialle; Kathryn R Bowles; Katia de Paiva Lopes; Kristen Whitney; Diana K Dangoor; Hadley Walsh; Edoardo Marcora; Marco M Hefti; Alicia Casella; Cheick T Sissoko; Manav Kapoor; Gloriia Novikova; Evan Udine; Garrett Wong; Weijing Tang; Tushar Bhangale; Julie Hunkapiller; Gai Ayalon; Robert R Graham; Jonathan D Cherry; Etty P Cortes; Valeriy Y Borukov; Ann C McKee; Thor D Stein; Jean-Paul Vonsattel; Andy F Teich; Marla Gearing; Jonathan Glass; Juan C Troncoso; Matthew P Frosch; Bradley T Hyman; Dennis W Dickson; Melissa E Murray; Johannes Attems; Margaret E Flanagan; Qinwen Mao; M-Marsel Mesulam; Sandra Weintraub; Randy L Woltjer; Thao Pham; Julia Kofler; Julie A Schneider; Lei Yu; Dushyant P Purohit; Vahram Haroutunian; Patrick R Hof; Sam Gandy; Mary Sano; Thomas G Beach; Wayne Poon; Claudia H Kawas; María M Corrada; Robert A Rissman; Jeff Metcalf; Sara Shuldberg; Bahar Salehi; Peter T Nelson; John Q Trojanowski; Edward B Lee; David A Wolk; Corey T McMillan; C Dirk Keene; Caitlin S Latimer; Thomas J Montine; Gabor G Kovacs; Mirjam I Lutz; Peter Fischer; Richard J Perrin; Nigel J Cairns; Erin E Franklin; Herbert T Cohen; Towfique Raj; Inma Cobos; Bess Frost; Alison Goate; Charles L White Iii; John F Crary
Journal:  Acta Neuropathol       Date:  2021-11-01       Impact factor: 15.887

5.  Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.

Authors:  Xi Chen; Kaitlin E Cassady; Jenna N Adams; Theresa M Harrison; Suzanne L Baker; William J Jagust
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

Review 6.  Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET.

Authors:  Hiroshi Matsuda; Yoko Shigemoto; Noriko Sato
Journal:  Jpn J Radiol       Date:  2019-09-06       Impact factor: 2.374

7.  Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.

Authors:  Merilee Teylan; Charles Mock; Kathryn Gauthreaux; Yen-Chi Chen; Kwun C G Chan; Jason Hassenstab; Lilah M Besser; Walter A Kukull; John F Crary
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

Review 8.  Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.

Authors:  Bruno Dubois; Nicolas Villain; Giovanni B Frisoni; Gil D Rabinovici; Marwan Sabbagh; Stefano Cappa; Alexandre Bejanin; Stéphanie Bombois; Stéphane Epelbaum; Marc Teichmann; Marie-Odile Habert; Agneta Nordberg; Kaj Blennow; Douglas Galasko; Yaakov Stern; Christopher C Rowe; Stephen Salloway; Lon S Schneider; Jeffrey L Cummings; Howard H Feldman
Journal:  Lancet Neurol       Date:  2021-04-29       Impact factor: 59.935

Review 9.  Amyloid-β-independent regulators of tau pathology in Alzheimer disease.

Authors:  Rik van der Kant; Lawrence S B Goldstein; Rik Ossenkoppele
Journal:  Nat Rev Neurosci       Date:  2019-11-28       Impact factor: 34.870

10.  Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging.

Authors:  Alifiya Kapasi; Lei Yu; Patricia A Boyle; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Neurology       Date:  2020-08-04       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.